Your browser doesn't support javascript.
loading
DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis.
Kobatake, Kohei; Ikeda, Kenichiro; Nakata, Yuichiro; Yamasaki, Norimasa; Kanai, Akinori; Sekino, Yohei; Takemoto, Kenshiro; Fukushima, Takafumi; Babasaki, Takashi; Kitano, Hiroyuki; Goto, Keisuke; Hayashi, Tetsutaro; Sentani, Kazuhiro; Teishima, Jun; Kaminuima, Osamu; Hinata, Nobuyuki.
Afiliação
  • Kobatake K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan. Electronic address: kkobatake@hiroshima-u.ac.jp.
  • Ikeda K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Nakata Y; Chromatin Dynamics in Stem Cells and Cancer Lab, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL.
  • Yamasaki N; Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Kanai A; Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa-shi, Chiba, Japan.
  • Sekino Y; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Takemoto K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Fukushima T; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Babasaki T; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Kitano H; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Goto K; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Hayashi T; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Sentani K; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Teishima J; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Kaminuima O; Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Hinata N; Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
Urol Oncol ; 40(10): 456.e9-456.e18, 2022 10.
Article em En | MEDLINE | ID: mdl-35918249

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article